BCDA: Altman Peter discloses a purchase
By AlphaYouPublished Form 4
Altman Peter
Reporting filer
Altman Peter reported Purchase in BioCardia, Inc.: 1900 units of Common Stock, dated 2026-09-23. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 24, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Altman Peter | 2026-09-23 | P | Purchase | 1900 | 1.05 | 383,885 | 1 day | Filed terms
|
Common Stock
- Owner
- Altman Peter
- Date
- 2026-09-23
- Code
- P
- Action
- Purchase
- Quantity
- 1900
- Price
- 1.05
- Following holdings
- 383,885
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-23
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Shares: 1900
- id: F1
- transaction Price Per Share: 1.05
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 383885
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Altman Peter: President and CEO, Director.
- F1: This transaction was executed in multiple trades ranging from $1.04 to $1.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Original sources
Prepared automatically from public filing data. Report a correction.